Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy.
Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy.
复制标题
DOI:
10.1016/j.toxrep.2017.06.002
复制
发表时间:
2017
影响因子:
--
通讯作者:
Sil PC
中科院分区:
文献类型:
--
作者:
Basak P;Sadhukhan P;Sarkar P;Sil PC
The Nuclear factor erythroid2-related factor2 (Nrf2), a master regulator of redox homoeostasis, is a key transcription factor regulating a wide array of genes for antioxidant and detoxification enzymes. It protects organs from various kinds of toxic insults. On the other hand, activation of Nrf2 is also correlated with cancer progression and chemoresistance. Downregulation of Nrf2 activity has attracted an increasing amount of attention as it may provide an alternative cancer therapy. In this review, we examine recent studies on roles of Nrf2 in several pathophysiological conditions emphasising cancer. We discuss elaborately the current knowledge on Nrf2 regulation including KEAP1-dependent and KEAP1-independent cascades. KEAP1/Nrf2 system is a master regulator of cellular response against a variety of environmental stresses. We also highlight several tightly controlled regulations of Nrf2 by numerous proteins, small molecules, toxic metals, etc. In addition, we evaluate the possible therapeutic approaches of increasing chemosensitivity via modulating Nrf2 signaling.